These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1056 related items for PubMed ID: 24666488

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
    Pedrazzoli P, Da Prada GA, Giorgiani G, Schiavo R, Zambelli A, Giraldi E, Landonio G, Locatelli F, Siena S, Della Cuna GR.
    Cancer; 2002 May 01; 94(9):2409-15. PubMed ID: 12015766
    [Abstract] [Full Text] [Related]

  • 44. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.
    Yoshimi A, Strahm B, Baumann I, Furlan I, Schwarz S, Teigler-Schlegel A, Walther JU, Schlegelberger B, Göhring G, Nöllke P, Führer M, Niemeyer CM.
    Biol Blood Marrow Transplant; 2014 Mar 01; 20(3):425-9. PubMed ID: 24316460
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Clinical applications of haploidentical hematopoietic stem cell transplantation in severe aplastic anemia.
    Zhang P, Feng K, Xue Y, Zhang CX, Wang Y, Li XL.
    Eur Rev Med Pharmacol Sci; 2017 Jan 01; 21(1):155-161. PubMed ID: 28121342
    [Abstract] [Full Text] [Related]

  • 47. Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch.
    Slack JL, Dueck AC, Fauble VD, Sproat LO, Reeder CB, Noel P, Khera N, Betcher JA, Klein JL, Leis JF, Adams RH.
    Biol Blood Marrow Transplant; 2013 Aug 01; 19(8):1167-74. PubMed ID: 23664940
    [Abstract] [Full Text] [Related]

  • 48. A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor.
    Devillier R, Fürst S, Crocchiolo R, El-Cheikh J, Castagna L, Harbi S, Granata A, D'Incan E, Coso D, Chabannon C, Picard C, Etienne A, Calmels B, Schiano JM, Lemarie C, Stoppa AM, Bouabdallah R, Vey N, Blaise D.
    Am J Hematol; 2014 Jan 01; 89(1):83-7. PubMed ID: 24108528
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.
    Chen YB, Coughlin E, Kennedy KF, Alyea EP, Armand P, Attar EC, Ballen KK, Cutler C, Dey BR, Koreth J, McAfee SL, Spitzer TR, Antin JH, Soiffer RJ, Ho VT.
    Biol Blood Marrow Transplant; 2013 Jun 01; 19(6):981-7. PubMed ID: 23562738
    [Abstract] [Full Text] [Related]

  • 52. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
    Bethge WA, Faul C, Bornhäuser M, Stuhler G, Beelen DW, Lang P, Stelljes M, Vogel W, Hägele M, Handgretinger R, Kanz L.
    Blood Cells Mol Dis; 2008 Jun 01; 40(1):13-9. PubMed ID: 17869547
    [Abstract] [Full Text] [Related]

  • 53. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
    Lee JH, Choi SJ, Lee JH, Lee YS, Seol M, Ryu SG, Lee JS, Kim WK, Lee KH.
    Bone Marrow Transplant; 2005 Apr 01; 35(8):755-61. PubMed ID: 15735661
    [Abstract] [Full Text] [Related]

  • 54. Engraftment of heavily transfused patients with severe aplastic anemia with a fludarabine-based regimen.
    Wang SB, Li L, Pan XH, Hu DM, Peng LH, Liu L, Xie ZJ, Yin B, Sun XJ, Yu J, Liang Y.
    Clin Transplant; 2013 Apr 01; 27(2):E109-15. PubMed ID: 23387380
    [Abstract] [Full Text] [Related]

  • 55. Allogeneic hematopoietic cell transplantation without total body irradiation from unrelated donor in adult patients with idiopathic aplastic anemia: fludarabine versus cyclophosphamide-ATG.
    Kim H, Lee KH, Kim I, Sohn SK, Jung CW, Joo YD, Kim SH, Kim BS, Choi JH, Kwak JY, Kim MK, Bae SH, Shin HJ, Won JH, Lee WS, Oh S, Kim HJ, Park JH, Korean Society of Blood and Marrow Transplantation.
    Leuk Res; 2014 Jul 01; 38(7):730-6. PubMed ID: 24840870
    [Abstract] [Full Text] [Related]

  • 56. Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia.
    McGuinn C, Geyer MB, Jin Z, Garvin JH, Satwani P, Bradley MB, Bhatia M, George D, Duffy D, Morris E, van de Ven C, Schwartz J, Baxter-Lowe LA, Cairo MS.
    Pediatr Blood Cancer; 2014 Jul 01; 61(7):1289-94. PubMed ID: 24623601
    [Abstract] [Full Text] [Related]

  • 57. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H, Al-Shammari Z, Al-Ghonaium A, Al-Dhekri H, Al-Muhsen S, Al-Saud B, Arnaout R, Al-Seraihy A, Al-Jefri A, Al-Ahmari A, Ayas M, El-Solh H.
    Biol Blood Marrow Transplant; 2010 Jun 01; 16(6):818-23. PubMed ID: 20079864
    [Abstract] [Full Text] [Related]

  • 58. A fludarabine-based conditioning regimen for severe aplastic anemia.
    Chan KW, Li CK, Worth LL, Chik KW, Jeha S, Shing MK, Yuen PM.
    Bone Marrow Transplant; 2001 Jan 01; 27(2):125-8. PubMed ID: 11281379
    [Abstract] [Full Text] [Related]

  • 59. Combined use of Chinese medicine with allogeneic hematopoietic stem cell transplantation for severe aplastic anemia patients.
    Ye BD, Zhang X, Shao KD, Chen D, Zhang Y, Wu DJ, Yu QH, Shen JP, Shen YP, Zhou YH.
    Chin J Integr Med; 2014 Dec 01; 20(12):903-9. PubMed ID: 25428338
    [Abstract] [Full Text] [Related]

  • 60. [Haploidentical hematopoietic stem cell transplantation for the treatment of severe aplastic anemia in children].
    Liu Y, Tang SQ, Huang WR, Li HH, Zhao Y, Bo J, Zhang N, Wang F, Yu L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug 01; 21(4):985-9. PubMed ID: 23998598
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.